Your session is about to expire
← Back to Search
Acetaminophen for Postoperative Pain
Study Summary
This trial will compare IV and oral acetaminophen to reduce pain and opioid use during ambulatory surgery to help speed up patient discharge.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My health is good to moderately impaired.I have been taking more than 20 mg of oxycodone daily for the last month.I have chronic pain not related to my back.I cannot take acetaminophen due to an allergy or liver issues.I have had surgery to correct or adjust a previous procedure.I am older than 18 years.I weigh less than 50 kg.I weigh more than 50 kg.
- Group 1: Group 1: IV acetaminophen and PO placebo
- Group 2: Group 2: PO acetaminophen
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the indications for administering PO acetaminophen to Group 2 patients?
"Group 2: Acetaminophen administered orally is a viable therapeutic option for catarrh, rhinorrhea, musculoskeletal pain and muscle spasms."
Has recruitment for this clinical trial commenced?
"Clinicaltrials.gov reports indicate that this clinical trial is presently recruiting patients, having been first posted on March 18th 2021 and last updated on August 15th 2023."
Have other experiments employed oral acetaminophen in Group 2?
"Currently, there are 74 studies looking into Group 2: PO acetaminophen. Of those trials, 24 have advanced to Phase 3 and the bulk of them can be found in Saint Louis Missouri yet 703 other medical centres also run these experiments."
To what extent is Group 2: PO acetaminophen hazardous to human health?
"Our team at Power evaluated the safety of Group 2: PO acetaminophen to be a 3 due to pre-existing clinical data suggesting efficacy and numerous rounds of testing validating its safety."
How many patients are currently involved in this clinical investigation?
"Affirmative, information on clinicaltrials.gov suggests that this research is still actively seeking participants. Initially posted on March 18th 2021, the study was last modified on August 15th 2023 and requires 82 patients from a single centre to complete recruitment objectives."
Share this study with friends
Copy Link
Messenger